8 June 2005   
News
Executive Vice President's Message
Milestone ISO/TC 212 Meeting in DC
Volunteer Focus
Press Releases
Standards Status
Vote and Deadlines
New CLSI Documents
New ISO Standards
Terminology Focus
Events and Exhibits
Upcoming Events
Calendar of Meetings
Participating in CLSI
Volunteer
New and Sustaining Member List
Update Your Subscription
 
CLSI Home Page
Search Past Issues
Update Your Contact Information
Print this article Print all articles
 
 
Standards Status

Vote and Deadlines
Interference Testing in Clinical Chemistry (EP7-A2); Preparation and Testing of Reagent Water in the Clinical Laboratory (C3-P4)

Clinical and Laboratory Standards Institute (CLSI) announces that the following are submitted for vote as candidate-for-advancement consensus documents:

 

EP7-A2—Interference Testing in Clinical Chemistry; Approved Guideline—Second Edition
CLSI guideline Interference Testing in Clinical Chemistry (EP7-A2) enables manufacturers and laboratories to evaluate interfering substances in the context of medical needs, and to inform their customers of known sources of medically significant error.  The deadline for the completed ballot for EP7-A2 to be received at CLSI is 8 August 2005.

 

C3-P4Preparation and Testing of Reagent Water in the Clinical Laboratory; Proposed Guideline—Fourth Edition
This document provides guidelines on water purified for clinical laboratory use; methods for monitoring water quality and testing for specific contaminants; and water system design considerations. The deadline for the completed ballot for C3-P4 to be received at CLSI is 6 September 2005.

 

Second Notice

 

C34-A2Sweat Testing:  Sample Collection and Quantitative Analysis; Approved Guideline—Second Edition (Reaffirmation)
The "sweat test," a quantitative measurement of chloride in sweat, is used to confirm the diagnosis of cystic fibrosis, but has been reported to have unacceptably high false-positive and false-negative rates.  This document provides much-needed comprehensive guidelines addressing the collection of sweat and the quantitative measurement of electrolytes in sweat.  The deadline for the completed ballot for C34-A2 to be received at CLSI is 5 July 2005.

 

Reaffirmation of a CLSI document is appropriate when the area committee determines that neither comments received nor any other substantive reasons support changes.  As with other candidate-for-advancement documents, only delegates from Active and Associate Active member organizations may vote, using a ballot found on CLSI Forums.   


Ballots are posted on the Forums section of our website, available to Active and Associate Active members.  Login to Forums to access the candidate-for-advancement forms, and send your completed ballot to the CLSI by the listed deadline. 

Not yet a voting member?  Find out more about
Active and Associate Active membership.

Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

Remember that we welcome and encourage comments from our voting members at each publication stage.  Comments on a candidate-for-advancement consensus document will be addressed by the committee prior to advancement.  In each document edition, a summary of comments on the prior edition is included, along with committee responses.  


  [ return to top ]

For more information or to contact us directly, please visit www.clsi.org
©2005 Clinical and Laboratory Standards Institute